US Stock MarketDetailed Quotes

VIR Vir Biotechnology

Watchlist
  • 7.860
  • +0.240+3.15%
Close Nov 27 16:00 ET
  • 7.860
  • 0.0000.00%
Post 16:20 ET
1.08BMarket Cap-2000P/E (TTM)

Vir Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-10.04%-171.48M
80.00%-77.85M
13.03%-109.39M
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
3,595.04%1.66B
356.48%35.13M
Net income from continuing operations
-30.78%-213.72M
28.95%-138.38M
53.69%-65.28M
-219.25%-615.12M
-14.14%-115.97M
-193.21%-163.41M
-154.63%-194.78M
-127.18%-140.96M
-2.41%515.84M
-119.34%-101.6M
Depreciation and amortization
-36.85%2.9M
-10.28%4.26M
-19.88%4.52M
186.76%19.45M
129.34%4.48M
172.65%4.59M
197.49%4.75M
263.27%5.64M
16.73%6.78M
28.40%1.95M
Deferred tax
--57K
----
----
93.00%-1.06M
---1.06M
--0
----
----
-200.00%-15.19M
----
Other non cash items
161.30%7.01M
-46.62%4.64M
111.86%3.61M
-110.10%-27.99M
24.24%5.17M
71.95%-11.43M
-97.88%8.69M
68.13%-30.41M
224.29%277.23M
-84.18%4.16M
Change In working capital
158.91%17.49M
99.07%-2.35M
-865.94%-82.15M
-145.78%-304.59M
-125.23%-32.75M
46.01%-29.69M
-143.11%-252.88M
174.02%10.73M
205.88%665.37M
121.25%129.82M
-Change in receivables
---54K
183.65%2.69M
-119.16%-401K
-100.07%-565K
-101.30%-3.61M
--0
-99.89%948K
100.47%2.09M
199.61%770.04M
140.90%278.17M
-Change in prepaid assets
-108.11%-2.18M
-63.93%6.42M
-80.68%1.83M
265.07%64.97M
121.39%10.78M
63.06%26.9M
440.77%17.81M
3,943.32%9.49M
-973.89%-39.36M
-808.91%-50.38M
-Change in payables and accrued expense
140.92%22.37M
97.13%-7.66M
-1,257.75%-29.27M
-2,317.55%-355.77M
52.54%-36.95M
35.43%-54.68M
7.91%-266.66M
-99.42%2.53M
-125.23%-14.72M
-206.98%-77.86M
-Change in other current assets
-18.61%1.74M
-166.22%-796K
95.67%-86K
118.32%2.16M
127.64%2.31M
162.86%2.13M
-260.75%-299K
-774.01%-1.98M
-695.35%-11.8M
-1,835.42%-8.36M
-Change in other current liabilities
21.69%-2.88M
-11.41%-3.49M
-30.98%-4.07M
-137.11%-13.05M
-6.13%-3.14M
-139.41%-3.68M
-503.08%-3.13M
-529.82%-3.11M
-928.41%-5.5M
-1,844.08%-2.96M
-Change in other working capital
-307.86%-1.51M
131.38%482K
-3,050.53%-50.16M
92.96%-2.35M
75.67%-2.14M
99.08%-369K
23.92%-1.54M
-90.33%1.7M
-136.18%-33.3M
-454.31%-8.79M
Cash from discontinued investing activities
Operating cash flow
-10.04%-171.48M
80.00%-77.85M
13.03%-109.39M
-146.82%-778.79M
-407.26%-107.93M
-232.17%-155.83M
-140.54%-389.25M
-122.87%-125.78M
3,595.04%1.66B
356.48%35.13M
Investing cash flow
Cash flow from continuing investing activities
301.18%118.6M
-8.12%211.61M
-71.02%28.42M
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
-747.54%-1.19B
59.44%-153.14M
Net PPE purchase and sale
36.70%-2.35M
96.97%-287K
80.50%-1.34M
68.28%-21.57M
87.81%-1.54M
80.43%-3.71M
54.09%-9.46M
56.62%-6.87M
-211.71%-68.01M
3.63%-12.6M
Net investment purchase and sale
319.71%121.37M
-11.63%211.89M
-71.64%29.76M
116.54%186.2M
26.51%-103.28M
91.42%-55.24M
195.25%239.77M
217.18%104.95M
-845.78%-1.13B
61.44%-140.54M
Cash from discontinued investing activities
Investing cash flow
301.18%118.6M
-8.12%211.61M
-71.02%28.42M
113.79%164.63M
31.56%-104.81M
91.10%-58.95M
184.57%230.32M
193.06%98.08M
-747.54%-1.19B
59.44%-153.14M
Financing cash flow
Cash flow from continuing financing activities
-88.81%31K
-7.46%2.94M
-93.52%152K
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
-65.35%34.76M
-64.53%2.01M
Net issuance payments of debt
39.39%-40K
-1.47%-69K
-4.55%-69K
-10.38%-287K
-12.99%-87K
-11.86%-66K
-13.33%-68K
-3.13%-66K
-0.39%-260K
-6.94%-77K
Net common stock issuance
----
----
----
--0
----
----
----
--0
-66.60%28.46M
--0
Proceeds from stock option exercised by employees
-79.30%71K
-10.04%3.01M
-90.43%221K
0.14%7.77M
-15.37%1.77M
-83.22%343K
6.59%3.35M
377.27%2.31M
-49.56%7.76M
-63.64%2.09M
Net other financing activities
----
----
----
----
----
----
----
108.35%100K
---1.2M
--0
Cash from discontinued financing activities
Financing cash flow
-88.81%31K
-7.46%2.94M
-93.52%152K
-78.48%7.48M
-16.46%1.68M
-86.05%277K
3.21%3.18M
-91.53%2.34M
-65.35%34.76M
-64.53%2.01M
Net cash flow
Beginning cash position
-53.82%317.18M
-78.58%180.47M
-69.90%261.29M
138.84%867.97M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
138.84%867.97M
-19.51%363.42M
35.23%983.97M
Current changes in cash
75.36%-52.85M
187.77%136.7M
-218.70%-80.82M
-220.24%-606.68M
-81.95%-211.06M
60.48%-214.51M
-122.54%-155.75M
-105.37%-25.36M
672.89%504.55M
68.15%-116M
End cash Position
-44.04%264.33M
-53.82%317.18M
-78.58%180.47M
-69.90%261.29M
-69.90%261.29M
-52.00%472.35M
-55.01%686.86M
0.82%842.61M
138.84%867.97M
138.84%867.97M
Free cash flow
-8.96%-173.84M
80.31%-78.51M
16.12%-111.26M
-150.17%-800.36M
-585.38%-109.46M
-261.30%-159.54M
-142.44%-398.7M
-124.83%-132.65M
2,398.43%1.6B
519.81%22.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -10.04%-171.48M80.00%-77.85M13.03%-109.39M-146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M3,595.04%1.66B356.48%35.13M
Net income from continuing operations -30.78%-213.72M28.95%-138.38M53.69%-65.28M-219.25%-615.12M-14.14%-115.97M-193.21%-163.41M-154.63%-194.78M-127.18%-140.96M-2.41%515.84M-119.34%-101.6M
Depreciation and amortization -36.85%2.9M-10.28%4.26M-19.88%4.52M186.76%19.45M129.34%4.48M172.65%4.59M197.49%4.75M263.27%5.64M16.73%6.78M28.40%1.95M
Deferred tax --57K--------93.00%-1.06M---1.06M--0---------200.00%-15.19M----
Other non cash items 161.30%7.01M-46.62%4.64M111.86%3.61M-110.10%-27.99M24.24%5.17M71.95%-11.43M-97.88%8.69M68.13%-30.41M224.29%277.23M-84.18%4.16M
Change In working capital 158.91%17.49M99.07%-2.35M-865.94%-82.15M-145.78%-304.59M-125.23%-32.75M46.01%-29.69M-143.11%-252.88M174.02%10.73M205.88%665.37M121.25%129.82M
-Change in receivables ---54K183.65%2.69M-119.16%-401K-100.07%-565K-101.30%-3.61M--0-99.89%948K100.47%2.09M199.61%770.04M140.90%278.17M
-Change in prepaid assets -108.11%-2.18M-63.93%6.42M-80.68%1.83M265.07%64.97M121.39%10.78M63.06%26.9M440.77%17.81M3,943.32%9.49M-973.89%-39.36M-808.91%-50.38M
-Change in payables and accrued expense 140.92%22.37M97.13%-7.66M-1,257.75%-29.27M-2,317.55%-355.77M52.54%-36.95M35.43%-54.68M7.91%-266.66M-99.42%2.53M-125.23%-14.72M-206.98%-77.86M
-Change in other current assets -18.61%1.74M-166.22%-796K95.67%-86K118.32%2.16M127.64%2.31M162.86%2.13M-260.75%-299K-774.01%-1.98M-695.35%-11.8M-1,835.42%-8.36M
-Change in other current liabilities 21.69%-2.88M-11.41%-3.49M-30.98%-4.07M-137.11%-13.05M-6.13%-3.14M-139.41%-3.68M-503.08%-3.13M-529.82%-3.11M-928.41%-5.5M-1,844.08%-2.96M
-Change in other working capital -307.86%-1.51M131.38%482K-3,050.53%-50.16M92.96%-2.35M75.67%-2.14M99.08%-369K23.92%-1.54M-90.33%1.7M-136.18%-33.3M-454.31%-8.79M
Cash from discontinued investing activities
Operating cash flow -10.04%-171.48M80.00%-77.85M13.03%-109.39M-146.82%-778.79M-407.26%-107.93M-232.17%-155.83M-140.54%-389.25M-122.87%-125.78M3,595.04%1.66B356.48%35.13M
Investing cash flow
Cash flow from continuing investing activities 301.18%118.6M-8.12%211.61M-71.02%28.42M113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M-747.54%-1.19B59.44%-153.14M
Net PPE purchase and sale 36.70%-2.35M96.97%-287K80.50%-1.34M68.28%-21.57M87.81%-1.54M80.43%-3.71M54.09%-9.46M56.62%-6.87M-211.71%-68.01M3.63%-12.6M
Net investment purchase and sale 319.71%121.37M-11.63%211.89M-71.64%29.76M116.54%186.2M26.51%-103.28M91.42%-55.24M195.25%239.77M217.18%104.95M-845.78%-1.13B61.44%-140.54M
Cash from discontinued investing activities
Investing cash flow 301.18%118.6M-8.12%211.61M-71.02%28.42M113.79%164.63M31.56%-104.81M91.10%-58.95M184.57%230.32M193.06%98.08M-747.54%-1.19B59.44%-153.14M
Financing cash flow
Cash flow from continuing financing activities -88.81%31K-7.46%2.94M-93.52%152K-78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M-65.35%34.76M-64.53%2.01M
Net issuance payments of debt 39.39%-40K-1.47%-69K-4.55%-69K-10.38%-287K-12.99%-87K-11.86%-66K-13.33%-68K-3.13%-66K-0.39%-260K-6.94%-77K
Net common stock issuance --------------0--------------0-66.60%28.46M--0
Proceeds from stock option exercised by employees -79.30%71K-10.04%3.01M-90.43%221K0.14%7.77M-15.37%1.77M-83.22%343K6.59%3.35M377.27%2.31M-49.56%7.76M-63.64%2.09M
Net other financing activities ----------------------------108.35%100K---1.2M--0
Cash from discontinued financing activities
Financing cash flow -88.81%31K-7.46%2.94M-93.52%152K-78.48%7.48M-16.46%1.68M-86.05%277K3.21%3.18M-91.53%2.34M-65.35%34.76M-64.53%2.01M
Net cash flow
Beginning cash position -53.82%317.18M-78.58%180.47M-69.90%261.29M138.84%867.97M-52.00%472.35M-55.01%686.86M0.82%842.61M138.84%867.97M-19.51%363.42M35.23%983.97M
Current changes in cash 75.36%-52.85M187.77%136.7M-218.70%-80.82M-220.24%-606.68M-81.95%-211.06M60.48%-214.51M-122.54%-155.75M-105.37%-25.36M672.89%504.55M68.15%-116M
End cash Position -44.04%264.33M-53.82%317.18M-78.58%180.47M-69.90%261.29M-69.90%261.29M-52.00%472.35M-55.01%686.86M0.82%842.61M138.84%867.97M138.84%867.97M
Free cash flow -8.96%-173.84M80.31%-78.51M16.12%-111.26M-150.17%-800.36M-585.38%-109.46M-261.30%-159.54M-142.44%-398.7M-124.83%-132.65M2,398.43%1.6B519.81%22.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data